Report summary

Notifier

Name of person with notification obligation

Anna Frostegård

Reason for notification

Closely associated

Person discharging managerial responsibilities

Anna Frostegård

Position

Other member of the company's administrative, management or supervisory body

Initial notification

Yes

Amendment

Details of amendment

Details of the Issuer/emission allowance market participant/auction platform/auctioneer/auction monitor

Name of issuer

Annexin Pharmaceuticals AB (publ)

Issuer´s LEI code

5493000JP703HGPJEX27

Details of transaction

Type of financial instrument	Financial instrument	ISIN code	Nature of transaction	Linked to the exercise of a share option programme	Volume	Unit	Price per unit	Currency code	Transaction date	Place of the transaction
BTA	Annexin Pharmaceuticals AB	SE0009664154	Subscription		2,910,622	Quantity	0.20	SEK	18/12/2023	Outside a trading venue

Aggregation

Financial instrument	ISIN code	Nature of transaction	Transaction date	Place of the transaction	Volume	Weighted average price
Annexin Pharmaceuticals AB	SE0009664154	Subscription	18/12/2023	Outside a trading venue	2,910,622 (Quantity)	0.20 SEK
				Total:	2,910,622

<< Back